NEW YORK ( 360Dx) – Sandstone Diagnostics announced today an additional $2.5 million in Series A financing to further develop its plasma preparation system.
The new financing was led by existing investor Hunt Holdings. New investors, including Laboratory Corporation of America and Cavendish Impact Fund, also participated.
The Pleasanton, California-based firm said the financing accelerates the development of its Zero Delay plasma preparation system for immediate blood plasma isolation and stabilization at the point of collection. The device leverages Sandstone's CentriFluidic technology platform.
The system is made up of a compact, battery-powered centrifuge and discs that collect and spin blood samples immediately following collection. This allows plasma from blood cells and other contaminants to be hermetically isolated in a few minutes.
According to Sandstone, providing superior sample purity and stability will "enhance a wide range of diagnostic applications." First generation DZ systems are currently being used in investigational evaluations.